Katarina D. Kovacevic

Author

Also Known As

K Kovacevic, K. Kovacevic, Katarina D. Kovacevic, Katarina D. Kovacevic Miljevic, Katarina Kovacevic, Katarina Kovačević

Publications

364

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Guardian Industries (United States)

About

Katarina D. Kovacevic is an author at Medical University of Vienna specializing in autoimmune disease, immunology, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	22
2	Allergy	1	1	22
3	Immunology	1	1	22
4	Pharmacology	1	1	22
5	Autoimmune Disease	1	1	22

Katarina D. Kovacevic

Publications

198

Citations

H-Index

Page 1

	Year	Citations
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial Katarina D. Kovacevic, Juergen Grafeneder, Christian Schörgenhofer, Haematologica	2021	35
The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients Katarina D. Kovacevic, Stefan Greisenegger, A. Langer, Scientific Reports	2021	34
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease Cihan Ay, Ingrid Pabinger, Katarina D. Kovacevic, Blood Advances	2022	27
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin Katarina D. Kovacevic, Nina Buchtele, Christian Schoergenhofer, Scientific Reports	2020	23
The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer, Blood ImmunologyPharmacotherapyAptamer Rondaptivon PegolInflammationThrombosis	2022	22
Echocardiographic Assessment of Ischaemic Mitral Regurgitation, Mechanism, Severity, Impact on Treatment Strategy and Long Term Outcome Nabil Naser, Alen Džubur, Zumreta Kušljugić, Acta Informatica Medica	2016	17
Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study Katarina D. Kovacevic, Florian J. Mayer, Bernd Jilma, Atherosclerosis	2019	16
von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo Katarina D. Kovacevic, Bernd Jilma, Shuhao Zhu, Thrombosis and Haemostasis	2020	14
Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers Christian Schoergenhofer, Nina Buchtele, Georg Gelbenegger, Scientific Reports	2019	10

Page 1